GJIA
MRNA icon

Glass Jacobson Investment Advisors’s Moderna MRNA Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$5.94K – 781
2024
Q2 		$5.94K Hold
50
– – ﹤0.01% 605
2024
Q1 		$5.33K Hold
50
– – ﹤0.01% 617
2023
Q4 		$4.97K Hold
50
– – ﹤0.01% 593
2023
Q3 		$5.17K Hold
50
– – ﹤0.01% 565
2023
Q2 		$6.08K Buy
+50
New +$6.67K ﹤0.01% 561
2022
Q4 		$8.98K Buy
+50
New +$8.18K ﹤0.01% 528

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Glass Jacobson Investment Advisors's MRNA Position: Q3 2024 in Review

Glass Jacobson Investment Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 50 shares — an estimated $5.94K sold.

Glass Jacobson Investment Advisors first reported a position in MRNA in Q4 2022 and held it in 6 quarters. The position peaked at $8.98K in Q4 2022. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Glass Jacobson Investment Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Glass Jacobson Investment Advisors sold 50 Moderna shares in Q3 2024, an estimated $5.94K.
  • Glass Jacobson Investment Advisors first reported a position in Moderna in Q4 2022 and held it in 6 quarters.
  • Glass Jacobson Investment Advisors's Moderna position peaked at $8.98K in Q4 2022.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Glass Jacobson Investment Advisors's 13F filing for Q3 2024, filed 15 Nov 2024.